Skip to main content
. 2021 Dec 18;58:103455. doi: 10.1016/j.msard.2021.103455

Fig. 2.

Fig. 2

(A) Linear regression analysis between the absolute number of CD20 pre-vaccination (T0) and SARS CoV-2 IgG Spike titre 3 weeks post-vaccination (T1) in IFN-treated MS subjects. Analysis was assessed by Spearman rank correlation and reported as coefficient of correlation (r). p-value less than 0.05 was considered statistically significant. (B) Linear regression analysis between the absolute number of CD20 pre-vaccination (T0) and SARS CoV-2 IgG Spike titre 3 weeks post-vaccination (T1) in DMF-treated MS subjects. Analysis was assessed by Spearman rank correlation and reported as coefficient of correlation (r). p-value less than 0.05 was considered statistically significant. (C) Linear regression analysis between the absolute number of lymphocytes pre-vaccination (T0) and SARS CoV-2 IgG Spike titre 3 weeks post-vaccination (T1) in GA-treated MS subjects. Analysis was assessed by Spearman rank correlation and reported as coefficient of correlation (r). p-value less than 0.05 was considered statistically significant.